Search

everythinglearnresearchcommunity

for

Search:↓

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

Effective symptom management in IBD improves quality of life and prevents complications.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

The Rotterdam Study aims to understand various diseases in older adults.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.